Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Stereotaxis, a manufacturer of advanced cardiology instrument control systems, has announced a leadership transition plan under which Michael Kaminski, currently president and COO and a member of the board, will assume the title and responsibilities of CEO, effective January 1, 2009.
Subscribe to our email newsletter
At that time, Mr Kaminski will replace Bevil Hogg, who has served as the CEO since 1997 and will remain an active member of the company’s board of directors.
Mr Kaminski joined Stereotaxis in April 2002 as COO. Prior to coming to Stereotaxis, Mr Kaminski spent nearly 20 years with Hill-Rom Company. Mr Kaminski has a BS in marketing from Indiana University and an MBA from Xavier University.
Mr Hogg said: “We have reached a point where my own expertise in creating a new technology and the organization to support it should ideally be succeeded by a leader who brings the experience, expertise and focus necessary for operational execution and who can lead Stereotaxis to greater commercial success.
“Therefore, I’ve been working with the board on a transition plan that involves my passing the CEO baton to Mike as of January 1, 2009. The board and I believe that Mike has demonstrated the operational capability as well as the strategic vision to drive this company forward and achieve increasing levels of shareholder returns.”